Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Minder vaak ziekenhuisopname met baloxavir-marboxil dan met neuraminidaseremmers
feb 2022 | Virale infecties